LicoisoflavanoneCAS# 66067-26-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 66067-26-3 | SDF | Download SDF |
| PubChem ID | 392443 | Appearance | Powder |
| Formula | C20H18O6 | M.Wt | 354.36 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5,7-dihydroxy-3-(5-hydroxy-2,2-dimethylchromen-6-yl)-2,3-dihydrochromen-4-one | ||
| SMILES | CC1(C=CC2=C(O1)C=CC(=C2O)C3COC4=CC(=CC(=C4C3=O)O)O)C | ||
| Standard InChIKey | JNDPLDZUOFZXIG-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C20H18O6/c1-20(2)6-5-12-15(26-20)4-3-11(18(12)23)13-9-25-16-8-10(21)7-14(22)17(16)19(13)24/h3-8,13,21-23H,9H2,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Targets | PPAR |
Licoisoflavanone Dilution Calculator
Licoisoflavanone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.822 mL | 14.1099 mL | 28.2199 mL | 56.4398 mL | 70.5497 mL |
| 5 mM | 0.5644 mL | 2.822 mL | 5.644 mL | 11.288 mL | 14.1099 mL |
| 10 mM | 0.2822 mL | 1.411 mL | 2.822 mL | 5.644 mL | 7.055 mL |
| 50 mM | 0.0564 mL | 0.2822 mL | 0.5644 mL | 1.1288 mL | 1.411 mL |
| 100 mM | 0.0282 mL | 0.1411 mL | 0.2822 mL | 0.5644 mL | 0.7055 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Licoisoflavone B
Catalog No.:BCN6695
CAS No.:66056-30-2
- Benzoylgomisin H
Catalog No.:BCN7242
CAS No.:66056-23-3
- Angeloylgomisin H
Catalog No.:BCN2843
CAS No.:66056-22-2
- Gomisin H
Catalog No.:BCN3902
CAS No.:66056-20-0
- Licoisoflavone A
Catalog No.:BCN2929
CAS No.:66056-19-7
- Glycyrin
Catalog No.:BCN7681
CAS No.:66056-18-6
- H-D-Arg(NO2)-OH
Catalog No.:BCC2871
CAS No.:66036-77-9
- (5Z)-7-Oxozeaenol
Catalog No.:BCC7724
CAS No.:66018-38-0
- 6-Demethoxytangeretin
Catalog No.:BCN3844
CAS No.:6601-66-7
- Cirsimaritin
Catalog No.:BCN4206
CAS No.:6601-62-3
- H-Nva-OH
Catalog No.:BCC2643
CAS No.:6600-40-4
- Psoralen
Catalog No.:BCN4219
CAS No.:66-97-7
- Tigloylgomisin H
Catalog No.:BCN6927
CAS No.:66069-55-4
- GW 542573X
Catalog No.:BCC7914
CAS No.:660846-41-3
- Nimodipine
Catalog No.:BCC3823
CAS No.:66085-59-4
- GW843682X
Catalog No.:BCC1614
CAS No.:660868-91-7
- Docosanol (Abreua)
Catalog No.:BCC3769
CAS No.:661-19-8
- Glochidone
Catalog No.:BCN4207
CAS No.:6610-55-5
- Glochidiol
Catalog No.:BCN4208
CAS No.:6610-56-6
- Pergolide mesylate
Catalog No.:BCC4464
CAS No.:66104-23-2
- 14,17-Epidioxy-28-nor-15-taraxerene-2,3-diol
Catalog No.:BCN1386
CAS No.:66107-60-6
- Levalbuterol tartrate
Catalog No.:BCC4217
CAS No.:661464-94-4
- Chromolaenide
Catalog No.:BCN7341
CAS No.:66148-25-2
- Cimicifugoside
Catalog No.:BCN2623
CAS No.:66176-93-0
Metabolites identification of bioactive licorice compounds in rats.[Pubmed:26311472]
J Pharm Biomed Anal. 2015 Nov 10;115:515-22.
Licorice (Glycyrrhiza uralensis Fisch.) is one of the most popular herbal medicines worldwide. This study aims to identify the metabolites of seven representative bioactive licorice compounds in rats. These compounds include 22beta-acetoxyl glycyrrhizin (1), licoflavonol (2), licoricidin (3), Licoisoflavanone (4), isoglycycoumarin (5), semilicoisoflavone B (6), and 3-methoxy-9-hydroxy-pterocarpan (7). After oral administration of 250mg/kg of 1 or 40mg/kg of 2-7 to rats, a total of 16, 43 and 31 metabolites were detected in the plasma, urine and fecal samples, respectively. The metabolites were characterized by HPLC/DAD/ESI-MS(n) and LC/IT-TOF-MS analyses. Particularly, two metabolites of 1 were unambiguously identified by comparing with reference standards, and 22beta-acetoxyl glycyrrhizin-6''-methyl ester (1-M2) is a new compound. Compound 1 could be readily hydrolyzed to eliminate the glucuronic acid residue. The phenolic compounds (4-7) mainly undertook phase II metabolism (glucuronidation or sulfation). Most phenolic compounds with an isoprenyl group (chain or cyclized, 2-5) could also undertake hydroxylation reaction. This is the first study on in vivo metabolism of these licorice compounds.
Separation, characterization and dose-effect relationship of the PPARgamma-activating bio-active constituents in the Chinese herb formulation 'San-Ao decoction'.[Pubmed:19924040]
Molecules. 2009 Oct 9;14(10):3942-51.
San-ao decoction (SAD), comprising Herba Ephedrae, Radix et Rhizoma Glycyrrhizae and Seneb Armeniacae Amarum, is one of the most popular traditional Chinese medicine (TCM) formulae for asthma. Peroxisome proliferator-activated receptors (PPARs) areey regulators of lipid and glucose metabolism and have become important therapeutic targets for various deseases, PPARgamma activation might exhibit anti-inflammatory properties in different chronic inflammatory processes. The EtOAc fraction of SAD showed a significant effect on PPARgamma activation. A simple and rapid method has been established for separation and characterization of the main compounds in the PPARgamma-activating fraction of SAD by ultra-fast HPLC coupled with quadropole time-of-flight mass pectrometry (UPLC-Q-TOF/MS). A total of 10 compounds were identified in the activating fraction of SAD, including amygdalin (1), liquiritin (2), 6'-acetyliquiritin (3), liquiritigenin (4), isoliquiritigenin (5), formononetin (6), Licoisoflavanone (7), glycycoumarin (8), glycyrol (9) and uercetin (10). The results also characterized formononetin as a predominant component in this fraction. The dose-effect relationship comparison study of formononetin and the EtOAc fraction of SAD by adding formononetin was performed, the results suggested that formononetin was the major component of the EtOAc fraction of SAD responsible for activating PPARgamma, and the method will possibly be applied to study the complex biological active constituents of other TCMs.
